DE2164766A1 - Skelettmuskelrelaxantien - Google Patents

Skelettmuskelrelaxantien

Info

Publication number
DE2164766A1
DE2164766A1 DE19712164766 DE2164766A DE2164766A1 DE 2164766 A1 DE2164766 A1 DE 2164766A1 DE 19712164766 DE19712164766 DE 19712164766 DE 2164766 A DE2164766 A DE 2164766A DE 2164766 A1 DE2164766 A1 DE 2164766A1
Authority
DE
Germany
Prior art keywords
diazepam
cyclobenzaprine
skeletal muscle
oil
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19712164766
Other languages
German (de)
English (en)
Inventor
Carl Edward Ambler Pa. Nelson (V.StA.). A61k 27-00
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2164766A1 publication Critical patent/DE2164766A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19712164766 1970-12-28 1971-12-27 Skelettmuskelrelaxantien Pending DE2164766A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10217470A 1970-12-28 1970-12-28

Publications (1)

Publication Number Publication Date
DE2164766A1 true DE2164766A1 (de) 1972-08-03

Family

ID=22288497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712164766 Pending DE2164766A1 (de) 1970-12-28 1971-12-27 Skelettmuskelrelaxantien

Country Status (6)

Country Link
AU (1) AU464883B2 (enExample)
CA (1) CA966422A (enExample)
DE (1) DE2164766A1 (enExample)
FR (1) FR2120069B1 (enExample)
GB (1) GB1339636A (enExample)
NL (1) NL7116917A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110558A1 (it) 2011-04-06 2012-10-07 Campiglio Consulting Srl Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale

Also Published As

Publication number Publication date
FR2120069B1 (enExample) 1975-03-14
GB1339636A (en) 1973-12-05
CA966422A (en) 1975-04-22
AU464883B2 (en) 1975-09-11
AU3684671A (en) 1973-06-21
FR2120069A1 (enExample) 1972-08-11
NL7116917A (enExample) 1972-06-30

Similar Documents

Publication Publication Date Title
DE68905096T2 (de) Niacin und guar-mehl enthaltende zusammensetzung.
DE69925407T2 (de) Präparat zur perkutan Verabreichung enthaltend Donepezil Hydrochlorid
DE69009684T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
EP0188810B1 (de) Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Verhinderung oder Behandlung posttraumatischer Nervenschäden nach unfallbedingten Rückenmarks- und/oder Gehirntraumen
EP0248047A1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
EP0241809A1 (de) Synergistische Kombination von Amantadin und Selegilin
DE3611194A1 (de) Cancerostatisches mittel
DE3786893T2 (de) Piperidinderivat zur Schmerzbehandlung.
DE69205158T2 (de) Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE3390116C2 (de) Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
EP1001756B1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
DE60124516T2 (de) Kombination des lezithins mit ascorbinsäure
DE3650735T2 (de) Verwendung von Cholin oder Cholin freisetzenden Verbindungen zur Verringerung der Empfingdung von Ermüdung
DE2164766A1 (de) Skelettmuskelrelaxantien
DE69918152T2 (de) Behandlung von verdauungsstörungen
DE602004003173T2 (de) Verwendung von konjugierter Linolsäure zur Behandlung der Erkältung
EP0820771A2 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
DE3213579C2 (enExample)
DE60012183T2 (de) Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen
DE3820817C2 (de) Antileptikum
DE1792282B1 (de) Antivirusmittel
DE2518509B2 (de) Pharmazeutisches Mittel für Antitumoraktivität, enthaltend Abrin
DE2319473A1 (de) Ricinhaltiges pharmazeutisches material mit antikrebswirkung

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection